DK3016970T3 - O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf - Google Patents

O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf Download PDF

Info

Publication number
DK3016970T3
DK3016970T3 DK14734515.1T DK14734515T DK3016970T3 DK 3016970 T3 DK3016970 T3 DK 3016970T3 DK 14734515 T DK14734515 T DK 14734515T DK 3016970 T3 DK3016970 T3 DK 3016970T3
Authority
DK
Denmark
Prior art keywords
mannosyltransferase
defected
filaments
methods
spot cells
Prior art date
Application number
DK14734515.1T
Other languages
English (en)
Inventor
Jari Natunen
Jukka Hiltunen
Anne Huuskonen
Markku Saloheimo
Christian Ostermeier
Benjamin Patrick Sommer
Ramon Wahl
Original Assignee
Glykos Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48740957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3016970(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glykos Finland Oy filed Critical Glykos Finland Oy
Application granted granted Critical
Publication of DK3016970T3 publication Critical patent/DK3016970T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01109—Dolichyl-phosphate-mannose-protein mannosyltransferase (2.4.1.109)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
DK14734515.1T 2013-07-04 2014-07-03 O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf DK3016970T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13175141 2013-07-04
PCT/EP2014/064248 WO2015001049A1 (en) 2013-07-04 2014-07-03 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof

Publications (1)

Publication Number Publication Date
DK3016970T3 true DK3016970T3 (da) 2019-06-24

Family

ID=48740957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14734515.1T DK3016970T3 (da) 2013-07-04 2014-07-03 O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf

Country Status (15)

Country Link
US (4) US20160376570A1 (da)
EP (1) EP3016970B1 (da)
KR (1) KR102111078B1 (da)
CN (1) CN105492457A (da)
BR (1) BR112015032695A2 (da)
CA (1) CA2916594C (da)
DK (1) DK3016970T3 (da)
ES (1) ES2739280T3 (da)
HR (1) HRP20191069T1 (da)
MX (1) MX364532B (da)
PL (1) PL3016970T3 (da)
RU (1) RU2016103373A (da)
SG (1) SG11201510814YA (da)
SI (1) SI3016970T1 (da)
WO (1) WO2015001049A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10513724B2 (en) 2014-07-21 2019-12-24 Glykos Finland Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
US20210388310A1 (en) * 2018-09-20 2021-12-16 Perfect Day, Inc. Methods and compositions for producing homokaryotic filamentous fungal cells
US20220025423A1 (en) * 2018-11-28 2022-01-27 Novozymes A/S Modified Filamentous Fungal Host Cells
CN110885810B (zh) * 2019-12-16 2021-03-23 华中农业大学 一种利用真核发酵制备得到的抑菌蛋白酶CmYC1及其应用
CN115976033B (zh) * 2022-12-14 2024-05-17 西南大学 瓜实蝇tssk1和tssk3基因及其应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4743546A (en) 1985-02-13 1988-05-10 Biotechnica International, Inc. Controlled gene excision
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
DE4244915C2 (de) 1992-08-14 1998-12-03 Widmar Prof Dr Tanner DNA-Moleküle codierend Proteine, die an der O-Glykosylierung von Proteinen beteiligt sind
US5958727A (en) 1996-09-13 1999-09-28 Novo Nordisk Biotech, Inc Methods for modifying the production of a polypeptide
DE19754622A1 (de) 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0021421D0 (en) 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
WO2002046437A2 (en) 2000-12-05 2002-06-13 The Penn State Research Foundation Methods and compositions for highly efficient production of heterologous proteins in yeast
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
NZ540743A (en) 2002-12-20 2008-06-30 Unilever Plc Preparation of antifreeze protein
ES2380022T3 (es) 2003-12-03 2012-05-07 Monika KRÖZ Proteínas de fusión a interleucina-11
PL1729795T3 (pl) 2004-02-09 2016-08-31 Human Genome Sciences Inc Białka fuzyjne albuminy
WO2006036817A2 (en) 2004-09-24 2006-04-06 Microbia, Inc. Fungal variants and uses thereof
CN101292024B (zh) * 2005-10-17 2012-04-18 诺维信公司 用于表达抗体的真菌突变体的用途
US8206949B2 (en) 2005-11-15 2012-06-26 Glycofi, Inc. Production of glycoproteins with reduced O-glycosylation
WO2007132949A1 (ja) 2006-05-16 2007-11-22 National Institute Of Advanced Industrial Science And Technology タンパク質の高分泌生産方法
EP2102366A4 (en) 2006-12-10 2010-01-27 Dyadic International Inc EXPRESSION AND HIGH-DROP SCREENING OF COMPLEX EXPRESSED DNA LIBRARIES IN FADENED MUSHROOMS
GB0711424D0 (en) 2007-06-13 2007-07-25 Novozymes Delta Ltd Recombinant transferrin mutants
CA2695830A1 (en) 2007-08-08 2009-02-12 Novozymes Biopharma Dk A/S Transferrin variants and conjugates
CN101945998B (zh) * 2008-02-20 2013-09-18 格利科菲公司 用于蛋白生产的载体和酵母菌株
US20090253173A1 (en) * 2008-04-08 2009-10-08 Danisco Us Inc., Genencor Division Filamentous fungi with inactivated protease genes for altered protein production
AU2009249314A1 (en) 2008-05-20 2009-11-26 Merck Sharp & Dohme Corp. Efficient production of heterologous proteins using mannosyl transferase inhibitors
MX2011001706A (es) * 2008-08-12 2011-03-24 Glycofi Inc Vectores mejorados y cepas de levadura para produccion de proteina: sobreexpresion de ca2+ atpasa.
WO2010034708A1 (en) 2008-09-23 2010-04-01 Unilever Plc A polynucleotide expression cassette
JP5936112B2 (ja) 2009-02-11 2016-06-15 アルブミディクス アクティーゼルスカブ アルブミン変異体及び複合体
WO2010128142A1 (en) 2009-05-07 2010-11-11 Novozymes Biopharma Dk A/S Method for purifying albumin
WO2010128145A1 (en) 2009-05-07 2010-11-11 Novozymes Biopharma Dk A/S Method of controlling o-linked glycosylation of antibodies
US8440456B2 (en) 2009-05-22 2013-05-14 Vib, Vzw Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins
CN104031961A (zh) 2009-10-16 2014-09-10 默沙东公司 生产成熟的人促红细胞生成素的方法以及包含获自该方法的人促红细胞生成素的组合物
MX350399B (es) 2009-12-18 2017-09-06 Novozymes Inc Metodos para producir polipeptidos en mutantes de trichoderma deficientes en proteasa.
EP2534255B1 (en) 2010-02-10 2017-05-10 Biocon Limited Method of reducing glycosylation of proteins, processes and proteins thereof
EP2539430B1 (en) * 2010-02-24 2016-09-14 Merck Sharp & Dohme Corp. Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris
RU2604811C2 (ru) 2010-05-27 2016-12-10 Мерк Шарп Энд Домэ Корп. Способ получения антител с улучшенными свойствами
US20120135461A1 (en) 2010-07-30 2012-05-31 William James Cook Production of glycoproteins with reduced o-glycosylation comprising the use of an alpha-1,2-mannosidase
KR20140018851A (ko) 2010-11-24 2014-02-13 노파르티스 인터내셔널 파마슈티칼 리미티드 N-아세틸글루코사미닐트랜스퍼라제 활성을 갖는 융합 효소
JP5885191B2 (ja) 2011-01-04 2016-03-15 国立研究開発法人産業技術総合研究所 糖鎖改変酵母及びそれを用いた糖タンパク質の製造方法
CN103764837A (zh) 2011-02-25 2014-04-30 默沙东公司 用于生产具有修饰的o-糖基化的蛋白的酵母菌株
KR20140028013A (ko) 2011-05-25 2014-03-07 머크 샤프 앤드 돔 코포레이션 개선된 특성을 갖는 Fc-함유 폴리펩티드를 제조하는 방법
AR087433A1 (es) 2011-08-08 2014-03-26 Merck Sharp & Dohme Analogos de insulina n-glicosilados
WO2013062886A1 (en) * 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Controlling o-glycosylation in lower eukaryotes
EP2773661A4 (en) 2011-10-31 2015-06-17 Merck Sharp & Dohme PROCESS FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES
WO2013066765A1 (en) 2011-11-01 2013-05-10 Merck Sharp & Dohme Corp. Mutation of tup1 in glycoengineered yeast
WO2013074598A1 (en) 2011-11-18 2013-05-23 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING
US9695454B2 (en) 2012-05-23 2017-07-04 Glykos Finland Oy Production of fucosylated glycoproteins
AU2013335065B2 (en) 2012-10-22 2018-10-25 Merck Sharp & Dohme Llc CRZ1 mutant fungal cells
US20150337274A1 (en) 2012-12-17 2015-11-26 Ming-Tang Chen Pmt2-, och1-, pmt5- mutant cells
WO2014126787A1 (en) 2013-02-13 2014-08-21 Merck Sharp & Dohme Corp. Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
WO2014138371A1 (en) 2013-03-06 2014-09-12 Glaxosmithkline Llc Host cells and methods of use
SG11201509201WA (en) 2013-05-06 2015-12-30 Cell Machines Inc Methods and compositions related to large scale production of proteins
WO2014195452A1 (en) 2013-06-07 2014-12-11 Novo Nordisk A/S Method for making mature insulin polypeptides
WO2015013116A1 (en) 2013-07-25 2015-01-29 Merck Sharp & Dohme Corp. Method for reducing the extent of o-mannosylation of glycoproteins
US20160215061A1 (en) 2013-10-08 2016-07-28 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB
WO2015073307A2 (en) 2013-11-13 2015-05-21 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO HUMAN DC-SIGN

Also Published As

Publication number Publication date
SI3016970T1 (sl) 2019-08-30
RU2016103373A3 (da) 2018-03-26
BR112015032695A2 (pt) 2017-10-24
ES2739280T3 (es) 2020-01-30
US20200040314A1 (en) 2020-02-06
EP3016970A1 (en) 2016-05-11
US20160376570A1 (en) 2016-12-29
PL3016970T3 (pl) 2019-09-30
HRP20191069T1 (hr) 2019-11-01
US20200362319A1 (en) 2020-11-19
KR20160030127A (ko) 2016-03-16
MX2016000128A (es) 2016-03-01
US20220213451A1 (en) 2022-07-07
WO2015001049A1 (en) 2015-01-08
CA2916594C (en) 2020-03-10
MX364532B (es) 2019-04-29
EP3016970B1 (en) 2019-05-22
US10724013B2 (en) 2020-07-28
RU2016103373A (ru) 2017-08-10
SG11201510814YA (en) 2016-01-28
CA2916594A1 (en) 2015-01-08
KR102111078B1 (ko) 2020-05-18
CN105492457A (zh) 2016-04-13

Similar Documents

Publication Publication Date Title
DK3087095T3 (da) FcRn-antagonist og fremgangsmåder til anvendelse
DK3043784T3 (da) Arylethere og anvendelser deraf
DK2844292T3 (da) ST2L-antagonister og fremgangsmåder til anvendelse
DK3044817T3 (da) Inverteret solcelle og fremgangsmåde til fremstilling deraf
DK3052485T3 (da) Heterocykliske forbindelser og anvendelser deraf
DK3192869T3 (da) Isoleret oligonukleotid og anvendelse deraf i nukleinsyresekvensering
DK2850202T3 (da) Fremgangsmåder og grupper
DK3381917T3 (da) Imidazopyridinforbindelser og anvendelser deraf
DK3086807T3 (da) Antistoffer og fremgangsmåder til anvendelse
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK3079719T3 (da) ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK3082902T3 (da) Kropsbåret injektor og anvendelsesmetode
DK3071248T3 (da) Vævsstilladsmateriale til vævsregenerering og fremgangsmåder til fremstilling
DK3089707T3 (da) Vævtransplantater og fremgangsmåder til fremstilling og brug af samme
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
FR3003076B1 (fr) Supercondensateur electrochimique
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3326642T3 (da) Langtidsvirkende koagulationsfaktorer og brugen deraf
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf
DK3022361T4 (da) Rambuk og fremgangsmåde til anvendelse deraf
DK3068505T3 (da) Spillesystem og -fremgangsmåde
DK2956471T3 (da) Il-1beta-hæmmersammensætning og anvendelse deraf